<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02541071</url>
  </required_header>
  <id_info>
    <org_study_id>Rombold_01</org_study_id>
    <nct_id>NCT02541071</nct_id>
  </id_info>
  <brief_title>Influence of the Noradrenergic System on the Formation of Intrusive Memories</brief_title>
  <official_title>Influence of the Noradrenergic System on the Formation of Intrusive Memories: An Experimental Approach With a Trauma Film Paradigm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intrusive memories of traumatic events are core features of posttraumatic stress disorder
      (PTSD) but little is known about the neurobiological formation of intrusions. The aim of this
      study was to determine whether the activity of the noradrenergic system during an
      intrusion-inducing stressor influences subsequent intrusive memories.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators conducted an experimental, double-blind, placebo-controlled study in 118
      healthy women. Prior to watching an established trauma film paradigm that induces short
      lasting intrusions, participants received a single dose of either 10 mg yohimbine,
      stimulating noradrenergic activity, or 0.15 mg clonidine, inhibiting noradrenergic activity,
      or placebo. The number of consecutive intrusions of the trauma film, the mean vividness of
      the intrusions and the mean degree of distress evoked by the intrusions were assessed during
      the following four days. Salivary cortisol and alpha-amylase were collected at seven time
      points prior to, and after the trauma film.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of intrusive memories</measure>
    <time_frame>four consecutive days</time_frame>
    <description>Measured with an intrusion diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vividness of intrusive memories</measure>
    <time_frame>four consecutive days</time_frame>
    <description>Measured with an intrusion diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of distress of intrusive memories</measure>
    <time_frame>four consecutive days</time_frame>
    <description>Measured with an intrusion diary</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">118</enrollment>
  <condition>Intrusive Memories</condition>
  <arm_group>
    <arm_group_label>Yohimbine and Stress Film</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of 10mg yohimbine before the trauma film.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo and Stress Film</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of placebo before the trauma film.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clonidine and Stress Film</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of 0.15mg clonidine before the trauma film.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stress Film</intervention_name>
    <arm_group_label>Yohimbine and Stress Film</arm_group_label>
    <arm_group_label>Placebo and Stress Film</arm_group_label>
    <arm_group_label>Clonidine and Stress Film</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Yohimbine</intervention_name>
    <arm_group_label>Yohimbine and Stress Film</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <arm_group_label>Clonidine and Stress Film</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Placebo and Stress Film</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy participants

          -  German on a native level

        Exclusion Criteria:

          -  former or present DSM IV Axis I disorders

          -  physical illnesses

          -  any medication intake (except oral contraceptive)

          -  history of sexual abuse or rape

          -  pregnancy or lactation period
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Roepke, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry and Psychotherapy, Charit√© University Medicine Berlin, Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2015</study_first_submitted>
  <study_first_submitted_qc>September 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2015</study_first_posted>
  <last_update_submitted>September 3, 2015</last_update_submitted>
  <last_update_submitted_qc>September 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Dipl.- Psych. Felicitas Rombold</investigator_full_name>
    <investigator_title>Dipl.-Psych.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Yohimbine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

